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Introduction
Modern biology increasingly relies on high-throughput 
techniques. One particular experiment no longer precisely 
answers one question; instead, partial answers are 
combined in different ways to answer many questions. This 
high-throughput trend challenges computational biologists 
to quickly extract as much useful information from the 
data as possible. Furthermore, novel drugs arrive on the 
market if and only if they undergo detailed analyses that 
investigate their micro-molecular (binding sites) as well 
as macro-molecular (pathways) actions. Generally, the 
challenge to computational biology is to annotate the 3D 
structure and function of as many proteins as possible at 
reasonable accuracy levels.
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The rapidly increasing quantity of protein sequence data continues to widen the gap between available sequences and annotations. 
Comparative modeling suggests some aspects of the 3D structures of approximately half of all known proteins; homology- and 
network-based inferences annotate some aspect of function for a similar fraction of the proteome. For most known protein sequences, 
however, there is detailed knowledge about neither their function nor their structure. Comprehensive efforts towards the expert curation of 
sequence annotations have failed to meet the demand of the rapidly increasing number of available sequences. Only the automated 
prediction of protein function in the absence of homology can close the gap between available sequences and annotations in the 
foreseeable future. This review focuses on two novel methods for automated annotation, and briefly presents an outlook on how 
modern web software may revolutionize the field of protein sequence annotation. First, predictions of protein binding sites and 
functional hotspots, and the evolution of these into the most successful type of prediction of protein function from sequence will be 
discussed. Second, a new tool, comprehensive in silico mutagenesis, which contributes important novel predictions of function and at 
the same time prepares for the onset of the next sequencing revolution, will be described. While these two new sub-fields of protein prediction 
represent the breakthroughs that have been achieved methodologically, it will then be argued that a different development might further 
change the way biomedical researchers benefit from annotations: modern web software can connect the worldwide web in any browser with the 
‘Deep Web’ (ie, proprietary data resources). The availability of this direct connection, and the  resulting access to a wealth of data, may impact 
drug discovery and development more than any existing method that contributes to protein annotation. 
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At the beginning of 2009, the genomes of more than 
900 organisms had been completely sequenced [1], and more 
than 7 million sequences were stored in protein databases 
(www.ebi.ac.uk/swissprot/sptr_stats/index.html) [2]. Many 
large-scale efforts have aimed to provide annotations for 
these sequences, for example, SWISS-PROT [3], Gene 
Ontology (GO) [4], the Human Proteomics Initiative (HPI; 
www.expasy.org/sprot/hpi/hpi_stat.html) [3], and the 
Protein Structure Initiative (PSI) [5]. GO, one of the major 
achievements of the last decade, systematically describes 
biological function using ontologies that encompass 
molecular function, cellular localization and biological 
processes. However, not even the best ontologies can rely 
solely on expert annotations, because the experts are 
unable to keep up with the rapid influx of new data. From 
among the ~ 7 million proteins of known sequence to date, 
only ~ 87,000 proteins have been manually annotated 
with a GO term (www.ebi.ac.uk/GOA/uniprot_release.html) 
[4] and ~ 5500 of the human proteins have GO numbers 
manually assigned by UniProt (www.ebi.ac.uk/GOA/
human_release.html). Most methods that predict function 
use classifications such as GO, and base their inferences 
on sequence similarity to proteins of experimentally 
characterized function [6-8]. SWISS-PROT undoubtedly 
constitutes the most comprehensive source of expert-
curated annotations of protein function. However, even 
this excellent resource infers as many annotations 
through sequence similarity as it does through explicit 
experimental support.
For some of the proteins for which some aspects of 
function have been probed experimentally, there are 
also experimentally determined 3D structures. However, 
for most proteins, experimental structures are not 
available [8,9]. Experimental structures are available for 
~ 55,000 known proteins (< 1%), of which less than half 
are distinct, at 95% sequence identity (www.rcsb.org/
pdb/statistics/clusterStatistics.do) [10]. For any detailed 
experiment that probes a particular protein, it is ultimately 
necessary to identify the mechanistic details describing 
the protein structure. Structural genomics efforts seek to 
experimentally determine the 3D structures for most 
protein families in a manner that optimizes the impact 
of each experimental structure for modeling [11-13]. 
The particular combination of many structures with 
many sequences enables novel inferences about protein 
function to be made [14,15]. The PSI, which drives 
structural genomics in the US [5], relies on computational 
biology to enrich the experimental data by many orders 
of magnitude [12]. This enrichment is currently mostly 
confined to the application of comparative modeling. 
Protein structure prediction methods have improved 
significantly over the last decade [16,17]. Methods such 
as Rosetta [18] and I-TASSER [19] can now generate good 
models for proteins that are similar to proteins of known 
structure, even if this similarity is not easily detectable. 
However, it remains unclear to what extent these 
improved prediction methods aid functional annotation.
Structural genomics radically altered many assumptions; 
for example, it was discovered that knowledge of the 
details of 3D protein structures does not automatically 
provide information about protein function [20,21]. 
However, knowledge of these structural details may help 
in the inference of function. This realization spawned the 
development of many methods for the prediction of protein 
function from 3D structure [22]. Generally, the choice of 
computational tools for the prediction of function depends 
on the type of desired prediction and on the amount 
of information available for the particular protein [23]. 
Currently available methods for protein function prediction 
cover a large number of techniques, from annotation 
transfer models using sequence, structure, and/or local 
motifs [24-26] to automatic text mining [27] and function 
predictions using machine learning [28-32]. Several 
approaches to the problem of obtaining sufficient data 
for protein function prediction combine various sources 
of information to improve the accuracy of the function 
predictions [33-35].
From molecular detail to the ambiguity of the 
system 
More recently, the trends in protein function prediction 
have split into two opposite directions. The first is at 
the level of the system, annotating the relevance of a 
certain protein to a phenotype [36,37], disease [38], 
module [39] or pathway [40]. This approach frequently 
focuses on coarse-grained aspects of function, analyzing 
similarities between entire modules/pathways or the 
similarity in the responses of proteins to particular 
experimental conditions (eg, correlated coexpression 
of responses to knockouts) [41,42]. This perspective 
ultimately ceases to be concerned with the physicochemical 
details of any particular protein. The second direction 
that protein function prediction has taken pertains to the 
increasingly detailed level of predicting molecular function 
from as much information as possible, including 3D 
structures [22,43], models, and stability assays [44]. This 
review will focus on some methods that have evolved 
in this direction over the last 2 years. In particular, two 
particular types of approach will be discussed: (i) those 
that predict binding sites; and (ii) those that identify 
patterns of functionally important residues based on the 
analysis of effects of non-synonymous SNPs (nsSNPs) or 
point mutants. These two novel types of functional 
annotation are relevant for drug design because they 
directly translate into discovering ways to alter a specific 
protein activity. 
Worldwide web surfing software to complement 
experimental methods 
The final focus of this review is on a new development that, 
initially, may appear to be unrelated to methods predicting 
aspects of protein function and structure. This novel 
advance connects two very different types of repositories: 
the 'general' worldwide web (typically interfaced through 
the Google search engine on any internet-enabled machine 
anywhere in the world), and the even larger underlying 
repository of data that is not visible to current search 
engines (such as data contained within publications or 
public databases that are not indexed for regular web 
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searches). The automatic extraction of otherwise 'hidden' 
functional and structural protein information from these 
(usually experimentally derived) resources is, effectively, 
at least equivalent in information gain to making de novo 
predictions or attempting to transfer annotations between 
similar molecules, if not more useful. Thus, accessing 
these supplies of data, as a novel method for the retrieval 
of molecular information, creates new perspectives on 
protein annotation. 
Predicting binding sites
Prediction of binding sites differs by type of 
interaction and amount of available information 
Some types of binding site can be recognized from 
3D protein structures with high levels of success 
[24,45,46]. Moreover, a recent study has illustrated the 
ability to differentiate proteins, based on the type of small 
molecule ligands that they bind, using only structural 
information about atoms in the binding site [47]. As 
high-accuracy experimental structures are not available 
for the majority of proteins, some methods predict 
protein binding sites [48] from predicted structures [26], or 
directly from protein sequences [30,49].
The binding sites of small substrates are very specific; 
computationally, such sites have to be inferred from 
sequence motifs (ie, by homology). Although largely 
successful, such methods are confined to a tiny subset of 
all binding sites. Generic prediction methods that identify 
yet-unknown binding sites have either not been successful 
to date, or they have to be specifically developed for 
particular substrates. One example of a successful method 
of this class pertains to the prediction of metal-binding 
sites [30,31]. Catalytic active sites are also extremely 
difficult to predict by methods other than motif-based 
approaches [49,50]. Arguably, the most successful binding 
site predictions from sequence alone pertain to the 
prediction of DNA- and RNA-binding sites [28,29].
Protein-protein binding arguably makes up the largest 
class of natural protein interactions [51]. Not surprisingly, 
a whole spectrum of methods exists that predict such 
binding sites [52,53]. Protein-protein interaction (PPI) 
sites are rather different from sites that bind small 
ligands, nucleic acids, metal ions and even small peptides. 
Interfaces between proteins and smaller substrates are 
typically cavities and concave clefts [54,55]. However, 
proteins tend to bind to each other through much larger 
and more structurally intricate surfaces [56,57].
The most accurate identification of PPI sites is 
accomplished by analyzing high-resolution experimental 
3D structures of the protein-protein complex. In the 
absence of experimental structures, computational models 
for complexes have been used to identify PPI sites [58]. 
However, protein-docking methods are still far from 
accurate enough to accomplish this feat for an abstract 
pair of molecules [59]. In fact, while docking methods 
could help in the identification of interaction sites, it is 
more common for docking solutions to rely on other 
methods for the prediction of PPI sites (such as those 
described below).
There are several different types of PPI. Some PPIs 
are obligatory (eg, between chains that do not function 
separately), and others are transient (eg, between chains 
that have a molecular function in both their bound and 
unbound states). Each type of interaction may be stabilized 
by different mechanisms, and therefore the interaction 
sites involved may have different characteristics [60].
Early binding-site prediction methods were developed 
using the little experimental data available, and were 
therefore mostly based on general, and often theoretical, 
parameters. For example, the method introduced by Kini 
and Evans relied on the observation of an abundance 
of proline in regions flanking PPI sites [61]. Jones and 
Thornton introduced a method that used experimental 
3D protein structures to predict whether a particular 
patch on the surface was likely to be an interaction site 
based on its topology, solvent accessibility and 
hydrophobicity [62]. Some of the more recent binding site 
prediction methods used a similar concept to that used 
by Jones and Thornton, and appeared to improve 
performance by using larger datasets with machine 
learning (eg, Bayesian networks) [63]. Other methods have 
also used the concept of patches on the protein surface 
to identify generic binding sites through evolutionary 
profiles; this idea was pioneered by the developers of the 
ConSurf tool [64] and was also used in HotPatch [55]. More 
recent methods, however, replace the concept of a 'patch' 
on the surface of the protein with the analysis of individual 
residues. Some of these methods use only sequence 
and sequence-derived features to predict interaction 
sites [60,65,66], but most require knowledge of the full 
experimental 3D structure of a protein [67-69]. Another 
category of protein binding site prediction methods relies 
on external sources of information, such as knowledge of 
specific PPIs, in an attempt to identify sequence motifs 
that may define PPI sites [70,71]. Similarly, it has been 
suggested that PPI data may be used to search for pairs 
of positions in multiple alignment matrices that have 
co-evolved in interacting proteins, and to identify these as 
putative interaction sites [72].
Protein-protein binding sites as new frontiers in 
drug design and development 
In the past, PPI sites that are not targeted by native 
small-molecule ligands have been avoided in the context 
of drug design [57,73]. However, recent studies have 
argued strongly for the design of molecules that target 
these sites [74]. Moreover, several drugs that are currently 
in development target PPI sites. Benzodiazepinedione 
and nutlin are two examples of drug classes that target 
PPI sites, and anticancer drugs belonging to both 
classes are currently under investigation. Although 
benzodiazepinedione and nutlin are structurally dissimilar, 
both target the interface between the protein HDM2 
(human double minute 2) and the tumor suppressor p53. 
The interaction between HDM2 and p53 is believed to 
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inhibit the tumor suppressing activity of p53. The 
specific binding of benzodiazepinedione or nutlin to the 
p53-binding site on HDM2 prevents the interaction between 
the two proteins and enables tumor suppression by p53 
[75,76]. Because the targeting of PPI sites is becoming 
increasingly popular in drug development [74,77], the 
importance of methods that predict potential interaction 
sites is increasing.
Another advantage of targeting PPI sites for therapeutic 
purposes is that the binding of the drug can specifically 
interfere with a damaging interaction without necessarily 
disrupting any other essential function of the binding 
partners; that is, these drugs are likely to reduce unwanted 
side effects, such as those associated with complete 
expression knockouts. Furthermore, given the size of 
PPIs (~ 2000 Å2) and the relative ease with which steric 
hindrance can disrupt an interaction, many different 
small molecules could be developed, each of which may 
be able to manipulate the same PPI (as demonstrated by 
benzodiazepinedione and nutlin, which bear no structural 
similarity to each other but abrogate the same interaction).
Binding hotspots accurately identified from 
sequences 
Not all residues at an interface contribute equally to the 
binding energy. In fact, most of the binding energy of a 
given interaction is associated with just a few residues, 
the so-called 'hotspots' [78,79]. Although all of the 
residues in a binding site contribute to the binding energy 
to some extent, those closer to the substrate contribute 
more. Is there anything more to the concept of hotspots 
than this? Protein-protein binding sites that are known in 
detail from experimental high-resolution structures are 
extremely diverse [60], and the only obvious commonality 
between them is hotspots [80]. This finding clearly extends 
beyond the triviality of 'some residues are more important 
than others' and thereby underlines the importance of 
targeting such generic sites.
A common method used to explore the importance of 
a residue to a particular interaction involves mutating 
it, typically to alanine, and measuring the effect of this 
substitution on the interaction [79]. This is often done 
sequentially on a large scale in a procedure known as an 
'alanine scan'. Many experiments have demonstrated that 
most interface residues can be mutated without affecting 
the affinity of the protein to its partners [81]. Those few 
residues that, upon mutation, change the affinity of 
the protein for its substrate are often defined as 
hotspots [78]. Overall, less than 5% of the residues in a 
typical 1200 to 2000 Å2 interface contribute more than 
2 kcal/mol to the binding energy. In small interfaces, this 
can correspond to as little as a single residue [78]. This 
fact interestingly coincides with the performance results 
reported by several binding site prediction methods: 
high levels of precision (accuracy) but low levels of recall 
(coverage). That is, when a residue is identified as part 
of the interaction site, this is usually correct, however, 
many of the residues in the interface are not identified 
at all. It has been suggested that the poor recall of 
interface-predicting methods should be attributed to the 
fact that some of these methods are actually predicting 
hotspots, rather than identifying all of the interface 
residues [80]. Several new methods, databases and 
analyses, have therefore attempted to identify hotspots 
explicitly, rather than all interface residues [68,82]. 
For example, consider the complex of the bacterial 
ribonuclease barnase and its inhibitor barstar 
(Figure 1A) [83]. The interface between the two proteins 
consists of more than 50 residues, of which 26 are on 
the barnase (Figure 1B). However, in an alanine scan only 
five of these residues were determined to be critical 
to the stability of the barnase-barstar complex 
(Figure 1C). The sequence of one chain of the barnase 
was used to predict the interaction sites using a 
sequence-based method (ISIS [65]; Figure 1D), and the 
structure of the same chain was used to predict interaction 
sites using a structure-based method (ProMate [46]; 
Figure 1E). The interaction sites predicted using these two 
methods were remarkably similar to those covered by the 
hotspots that were identified through the experimental 
alanine scans.
Computational methods aid in interaction 
modeling 
Computational 3D models of target proteins and studies 
of their interactions with suggested ligands have become 
useful tools in the development of novel drugs. The 
process of interaction modeling, however, has been 
compared to 'solving a three-dimensional jigsaw puzzle' 
where the pieces 'are the crystal structure of a scaffold 
protein, a ligand structure, and a set of amino-acid positions 
that will be mutated to create the binding site' [84]. The 
procedure involved in the design of a new drug includes 
iteratively searching through thousands of possible amino-
acid sequences to be mutated. The number of suggested 
sequences to be searched for and mutated could be 
significantly limited based on information provided by 
binding site predictions. Additionally, in silico mutagenesis 
studies (discussed below) could contribute to eliminating 
unlikely candidate sequences and prioritizing those 
mutations that have the most functional promise.
In silico mutagenesis and protein function 
prediction
Mutagenesis studies are one experimental means of 
annotating functionally important residues. For example, 
site-directed mutagenesis is performed to confirm or 
reject theories regarding functional involvement of specific 
residues [85,86]. Alanine scans (described in the previous 
section) are frequently employed to identify binding 
hotspots [78,79]. The systematic mutagenesis of large 
protein fragments, or even of entire proteins, has produced 
maps of protein function [87,88]. Experimental data are 
increasingly being complemented by the discovery of 
natural variations obtained from large-scale sequencing 
[89,90].
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Improvements to computational methods have enabled 
the prediction of the functional effects of single amino-
acid substitutions at acceptable levels of accuracy (for 
some methods, the overall accuracy can be significantly 
greater than 70%) [91-94]. The variety of existing methods 
aimed at this type of prediction ranges from mathematical 
models relying solely on evolutionary information [95], to 
rule-based systems [96] and machine learning methods, 
all of which are based on a diverse range of sequence and 
structural features [93,94,97].
Predictions of nsSNPs are now sufficiently accurate that 
the possibility of comprehensive in silico mutagenesis can 
be explored (ie, the computational prediction of functional 
effects for a large number of non-native mutants). One 
such study has shown that computational methods can 
fairly accurately identify functional sites annotated 
by alanine scans [98]. The researchers' recent results 
highlight the benefits of in silico mimicking of experimental 
protocols, which reduces the need for subsequent 
experiments in the wet laboratory environment 
(Figure 2) [98,99]. Obviously, this constitutes an amazing 
breakthrough given the extreme difference in costs of the 
two mutation methodologies. The experimental mutation of 
each residue in a protein to alanine is often prohibitive in 
cost, whereas the in silico mutation of each residue into 
all of the 19 non-native amino acids is relatively easy and 
inexpensive. The type of in silico sequence annotation 
described here has many potential applications. For 
example, per-residue predictions could be used in concert 
with biological intuition to speed up the experimental 
determination of active sites (Figure 2) [99].
The ability to computationally evaluate the functional 
effects of the mutation of any and all residues in a protein 
sequence, in a fraction of the time that it would take to do 
so experimentally, opens new perspectives for function 
prediction. For example, motifs of important residues 
that were identified by computational mutagenesis 
could potentially be used to correctly transfer functional 
annotations from one protein to another, as has been 
done with various other pattern-searching algorithms 
Figure 1. The prediction of protein interaction sites. 
(A) The complex between the bacterial ribonuclease barnase (green) and its inhibitor barstar (red) (PDB code: 1BRS). (B) When barstar is 
removed from barnase, the residues on the receptors at the interface are revealed. (C) Only a few of the residues at the interface – the hotpsots 
– were found to be critical for stabilizing the complex by experimental alanine scanning. (D) and (E) Two different prediction methods were used 
in an attempt to identify the hotspot residues in the area of the interface: (D) a sequence-based method (ISIS) [65,80], and (E) a structure-based 
method (ProMate) [46].
ISIS interaction sites identified from sequence
(Adapted with permission from Bromberg Y, Yachdav G, Ofran Y, Schneider R and Rost B © 2009 Bromberg Y, Yachdav G, Ofran Y, Schneider R and 
Rost B)
A
E
D C
B
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(eg, reference [100]). In another case, a mutability function 
could be computed that would allow various predictions at 
each position to be weighed to determine the functional 
importance of each residue. Additionally, cues from life can 
be taken to augment the power of in silico mutagenesis, 
for example, computationally extensively evaluating the 
areas of a protein that surround residues associated with 
a particular disease phenotype. Arguably, these sequence 
regions are prime candidates for evaluation of their 
involvement in protein function.
In order for in silico mutagenesis to be useful in terms of 
defining functional sites on proteins, it must be possible 
to differentiate between mutations that directly disrupt 
function and those that affect function indirectly, by 
disrupting the protein scaffolds. Currently, no method 
is able to differentiate between such direct and indirect 
effects. The difference between the predictions obtained 
from two methods (one predicting structural changes 
due to a substitution and the other annotating functional 
changes) could conceivably be used to identify residues 
that directly affected protein function, and those that did 
so indirectly. However, in order to be complementary, both 
methodologies must utilize similar quantities of available 
information. Although several methods successfully predict 
the effect of single amino-acid substitutions on protein 
structure [92,101], no method currently does this reliably 
from the protein sequence alone. This severely limits the 
Figure 2. Mutation-based predictions of Rab5 active sites. 
The structure of the tetramer of Ras-related protein Rab5A GTP-binding domains (PDB code: 1TU4) bound to GDP. The structure is 
highlighted based on SNAP predictions (from sequence information alone) of functional effects of single amino-acid substitutions. 
The colors indicate a range of SNAP [94] scores from 50 (red; predicted to be an active site) to -50 (blue; predicted to be a site with 
low or no activity). GDP is shown as a yellow wire model, the green wires are sulfate ions, and the magenta areas are cobalt ions. The 
clear correspondence of the predicted binding sites with the structurally likely binding grooves suggests that it is possible to predict 
protein active sites from sequence alone using in silico mutagenesis. (Molecular graphics images were produced using the UCSF 
Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco [119]). 
SNAP screening for non-acceptable polymorphisms
(Adapted with permission from Bromberg Y, Yachdav G, Ofran Y, Schneider R and Rost B © 2009 Bromberg Y, Yachdav G, Ofran Y, Schneider R 
and Rost B)
0-50 50
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number of sequences for which predictions can be made. 
Another set of currently unresolved issues pertains to 
the dynamic aspects of how structure impacts function. 
Could functional hotspots be identified by simulations 
that reveal the energetically most expensive substitutions 
[102]? Significant changes in structure will almost always 
affect function, but are there ways to distinguish between 
small structural effects that change binding and those 
that do not? These questions will need to be addressed in 
the near future.
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Marrying the web and the Deep Web
Worldwide web and Deep Web 
One of the challenges for biomedical researchers is the 
retrieval and assimilation of information that is acquired 
from the various resources that are accessed on a daily 
basis. For example, the worldwide web is typically accessed 
through generalized search engines such as Google, or 
specialized information retrieval systems such as Google 
Scholar (www.scholar.google.com), PubMed [103], Scirus 
[104], novo|seek (www.novoseek.com), or Medstory 
(www.medstory.com). Alternatively, the 'Deep Web' 
(or hidden web) exists, which is likely to be several orders 
of magnitude larger than the worldwide web as indexed 
by Google. In the 'Deep Web' category there are data 
collections such as GenBank [105], EMBL (the European 
Molecular Biology Laboratory) [106], and Uniprot [107], 
as well as the hundreds of web servers that offer a wide 
range of in-depth information, prediction and analytical 
tools [106,108-112]. Community projects such as 
Proteopedia have also recently begun to reproduce one 
of the most impressive phenomena of the last decade, 
namely the advance of community-driven knowledge 
gathering as exemplified by Wikipedia [113].
Every aspect of biomedical research could be accelerated 
if it was possible to switch easily between the worldwide 
web and the Deep Web. The straightforward solution, which 
would link these extremely heterogeneous and largely 
incompatible systems, would be the semantic web. 
However, biomedical information is typically complex, 
and semantic annotation of the many resources would 
require substantial additional manual effort. As this 
effort would not immediately result in a benefit to any 
particular group of scientists, incentive is limited. It is 
therefore expected that the development of the semantic 
web will require the development not only of strong 
knowledge constructs, such as ontologies, but also of 
smaller linking mechanisms that will provide an incentive 
to populate and publish semantic information. One of 
these potential linking mechanisms could be via the use 
of augmented browsing.
Augmented browsing 
Some methods, such as Whatizit [114] and iHop [115], 
systematically tag Medline abstracts that contain gene 
or protein names. However, there is some way to go 
before all scientific publishers consistently tag all of 
their content. An emerging approach, called augmented 
browsing, allows the tagging of all entities that relate 
to a specific field of interest and the exploration of 
the information by clicking on a tag. This on-demand 
tagging also ensures that the information delivered is up to 
date.
Augmented browsing tools are increasingly entering 
the biochemical sciences. For example, ChemGM [116], 
ConceptWeb (conceptweblinker.wikiprofessional.org) and 
the Conceptual Open Hypermedia Service (COHSE) [117] 
all tag entities such as genes, chemicals or diseases 
and link these tags to ontologies via popup windows, 
which then typically link to further data sources such as 
PubChem (pubchem.ncbi.nlm.nih.gov). Such popup 
windows are an effective means of displaying useful 
information on an entity, without the user needing to 
navigate away from the web page that was originally being 
viewed. Two methods of this type have recently been 
designed. Both Reflect (reflect.ws) and OnTheFly (onthefly.
embl.de; Figure 3) have created systems that enable 
users to tag the genes, proteins and small molecules that 
appear in any web page, PDF, or Microsoft Office 
document within a few seconds. Clicking on a tag opens 
a popup window that contains a concise summary of the 
most significant information about the tagged entity, and 
with direct links to commonly used source data entries. 
This type of service has a strong focus on ease of use 
and ease of installation, and has been shown to be 
useful to general life scientists, not just to computational 
biologists.
In the future, the accuracy and usability of such 
augmented browsing services will be improved by enabling 
Wikipedia-like community-based, collaborative editing 
of the summary popup information. Such a vehicle could 
significantly reduce the difficulties of populating the 
semantic web and would allow a broad range of users to 
build an improved scientific web.
Conclusion
Computational biology has contributed to the successful 
development of each new drug that reaches the market 
today. Nevertheless, most contemporary computational 
methods still provide only indirect (if often crucial) 
information. Many breakthroughs have characterized 
the transition from there being almost no methods for 
predicting protein structure and function reliably 
~ 15 years ago to the existence of a plethora of useful 
methods today. By many criteria, two very recent 
developments stand out in their relevance to drug 
discovery and development: (i) methods that predict 
interaction hotspots; and (ii) methods that can expedite the 
analysis of experimental data by realizing comprehensive 
in silico mutagenesis and accurately predict the effects 
of nsSNPs. These fields are young but have the potential 
to contribute significantly to the field, and both exemplify 
the amazing potential of computational biology to create 
results that accelerate progress at a lower cost than many 
experimental methods. The two methods also share 
another advantage in that their success currently appears 
to be limited only by the amount of data available (ie, they 
improve with every new experiment). Finally, a significant 
glimpse of the future was presented in this review, namely 
augmented browsing tools that will marry the worldwide 
web with the Deep Web, and will pioneer the advance 
of biomedical research into new scientific territory. 
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